Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
Cheddar News checks in with a coast-to-coast forecast of the weather for Wednesday, June 28, 2023.
The recent heat wave in the South has led to an uptick in ER hospitalizations, according to the CDC.
Drifting smoke from the ongoing wildfires across Canada is creating curtains of haze and raising air quality concerns throughout the Great Lakes region, and in parts of the central and eastern United States.
U.S. Confirms First Malaria Cases in 20 Years
Be Well: Olympic Gold Medalist Aly Raisman Talks Migraine Awareness
Using chainsaws, heavy machinery and controlled burns, the Biden administration is trying to turn the tide on worsening wildfires in the U.S. West through a multi-billion dollar cleanup of forests choked with dead trees and undergrowth.
Be Well: Pilates For Beginners
Four scientists will be living on a mock Mars base for a year that has been built inside the Johnson Space Center in Houston.
A cleaning company is facing a lawsuit after one of its janitors working at a university is accused of turning off a power supply to a freezer and destroying decades of scientific research.
A new study shows intermittent fasting is as effective as counting calories.
Load More